Bay Capital Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2055414 VIRGINIA BEACH, VA

Position in GILD

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$217,052

-$22,525 QoQ

Shares Held

1,718

-0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#1,877

of 2,266 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bay Capital Advisors, LLC holds $3,183,411 across 5 Drug Manufacturers - General names. GILD ranks #5 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,466	$1,758,364
2	ABBV	AbbVie Inc.	2,976	$748,880
3	AZN	Astrazeneca PLC	1,256	$238,162
4	JNJ	Johnson & Johnson	870	$220,953
5	GILD	Gilead Sciences, Inc. This page	1,718	$217,052

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$217,052	1,718	-0.1%	Shares	Sole	2026-07-21
2026-03-31	$239,577	1,719	0.0%	Shares	Sole	2026-04-22
2025-12-31	$210,990	1,719	—	Shares	Sole	2026-01-16
No filing history on record for this holder in this stock.